Exploring cell-based tolerance strategies for hand and face transplantation

Madeline Fryer, Johanna Grahammer, Saami Khalifian, Georg J. Furtmüller, W. P.Andrew Lee, Giorgio Raimondi, Gerald Brandacher

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Broader clinical application of reconstructive hand and face transplantation is hindered by the need for lifelong immunosuppression for allograft maintenance. In this review, we summarize various cell-based approaches to tolerance induction currently under investigation in both clinical and pre-clinical models to alleviate the need for chronic immunosuppression. These include strategies to induce mixed hematopoietic chimerism, therapy with T and B regulatory cells, regulatory macrophages, tolerogenic dendritic cells, and mesenchymal stem cells. The vascularized, intragraft bone components inherent to reconstructive transplants serve as a continuous source of donor-derived hematopoietic cells, and make hand and face transplants uniquely well suited for cell-based approaches to tolerance that may ultimately tilt the risk-benefit balance for these life-changing, but not life-saving, procedures.

Original languageEnglish (US)
Pages (from-to)1189-1204
Number of pages16
JournalExpert Review of Clinical Immunology
Volume11
Issue number11
DOIs
StatePublished - Nov 2 2015
Externally publishedYes

Fingerprint

Hand Transplantation
Facial Transplantation
Immunosuppression
Regulatory B-Lymphocytes
Chimerism
Regulatory T-Lymphocytes
Mesenchymal Stromal Cells
Dendritic Cells
Allografts
Hand
Macrophages
Maintenance
Transplants
Bone and Bones
Therapeutics

Keywords

  • mesenchymal stem cell
  • mixed chimerism
  • regulatory B cell
  • regulatory macrophage
  • regulatory T cell
  • tolerance
  • tolerogenic dendritic cell
  • vascularized composite allotransplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Fryer, M., Grahammer, J., Khalifian, S., Furtmüller, G. J., Lee, W. P. A., Raimondi, G., & Brandacher, G. (2015). Exploring cell-based tolerance strategies for hand and face transplantation. Expert Review of Clinical Immunology, 11(11), 1189-1204. https://doi.org/10.1586/1744666X.2015.1078729

Exploring cell-based tolerance strategies for hand and face transplantation. / Fryer, Madeline; Grahammer, Johanna; Khalifian, Saami; Furtmüller, Georg J.; Lee, W. P.Andrew; Raimondi, Giorgio; Brandacher, Gerald.

In: Expert Review of Clinical Immunology, Vol. 11, No. 11, 02.11.2015, p. 1189-1204.

Research output: Contribution to journalReview article

Fryer, M, Grahammer, J, Khalifian, S, Furtmüller, GJ, Lee, WPA, Raimondi, G & Brandacher, G 2015, 'Exploring cell-based tolerance strategies for hand and face transplantation', Expert Review of Clinical Immunology, vol. 11, no. 11, pp. 1189-1204. https://doi.org/10.1586/1744666X.2015.1078729
Fryer, Madeline ; Grahammer, Johanna ; Khalifian, Saami ; Furtmüller, Georg J. ; Lee, W. P.Andrew ; Raimondi, Giorgio ; Brandacher, Gerald. / Exploring cell-based tolerance strategies for hand and face transplantation. In: Expert Review of Clinical Immunology. 2015 ; Vol. 11, No. 11. pp. 1189-1204.
@article{db0e31caf7e24a289ff9c19d859b6619,
title = "Exploring cell-based tolerance strategies for hand and face transplantation",
abstract = "Broader clinical application of reconstructive hand and face transplantation is hindered by the need for lifelong immunosuppression for allograft maintenance. In this review, we summarize various cell-based approaches to tolerance induction currently under investigation in both clinical and pre-clinical models to alleviate the need for chronic immunosuppression. These include strategies to induce mixed hematopoietic chimerism, therapy with T and B regulatory cells, regulatory macrophages, tolerogenic dendritic cells, and mesenchymal stem cells. The vascularized, intragraft bone components inherent to reconstructive transplants serve as a continuous source of donor-derived hematopoietic cells, and make hand and face transplants uniquely well suited for cell-based approaches to tolerance that may ultimately tilt the risk-benefit balance for these life-changing, but not life-saving, procedures.",
keywords = "mesenchymal stem cell, mixed chimerism, regulatory B cell, regulatory macrophage, regulatory T cell, tolerance, tolerogenic dendritic cell, vascularized composite allotransplantation",
author = "Madeline Fryer and Johanna Grahammer and Saami Khalifian and Furtm{\"u}ller, {Georg J.} and Lee, {W. P.Andrew} and Giorgio Raimondi and Gerald Brandacher",
year = "2015",
month = "11",
day = "2",
doi = "10.1586/1744666X.2015.1078729",
language = "English (US)",
volume = "11",
pages = "1189--1204",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Exploring cell-based tolerance strategies for hand and face transplantation

AU - Fryer, Madeline

AU - Grahammer, Johanna

AU - Khalifian, Saami

AU - Furtmüller, Georg J.

AU - Lee, W. P.Andrew

AU - Raimondi, Giorgio

AU - Brandacher, Gerald

PY - 2015/11/2

Y1 - 2015/11/2

N2 - Broader clinical application of reconstructive hand and face transplantation is hindered by the need for lifelong immunosuppression for allograft maintenance. In this review, we summarize various cell-based approaches to tolerance induction currently under investigation in both clinical and pre-clinical models to alleviate the need for chronic immunosuppression. These include strategies to induce mixed hematopoietic chimerism, therapy with T and B regulatory cells, regulatory macrophages, tolerogenic dendritic cells, and mesenchymal stem cells. The vascularized, intragraft bone components inherent to reconstructive transplants serve as a continuous source of donor-derived hematopoietic cells, and make hand and face transplants uniquely well suited for cell-based approaches to tolerance that may ultimately tilt the risk-benefit balance for these life-changing, but not life-saving, procedures.

AB - Broader clinical application of reconstructive hand and face transplantation is hindered by the need for lifelong immunosuppression for allograft maintenance. In this review, we summarize various cell-based approaches to tolerance induction currently under investigation in both clinical and pre-clinical models to alleviate the need for chronic immunosuppression. These include strategies to induce mixed hematopoietic chimerism, therapy with T and B regulatory cells, regulatory macrophages, tolerogenic dendritic cells, and mesenchymal stem cells. The vascularized, intragraft bone components inherent to reconstructive transplants serve as a continuous source of donor-derived hematopoietic cells, and make hand and face transplants uniquely well suited for cell-based approaches to tolerance that may ultimately tilt the risk-benefit balance for these life-changing, but not life-saving, procedures.

KW - mesenchymal stem cell

KW - mixed chimerism

KW - regulatory B cell

KW - regulatory macrophage

KW - regulatory T cell

KW - tolerance

KW - tolerogenic dendritic cell

KW - vascularized composite allotransplantation

UR - http://www.scopus.com/inward/record.url?scp=84945439817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945439817&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2015.1078729

DO - 10.1586/1744666X.2015.1078729

M3 - Review article

C2 - 26289376

AN - SCOPUS:84945439817

VL - 11

SP - 1189

EP - 1204

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 11

ER -